Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

AstraZeneca
Colorcon
Harvard Business School
McKesson
McKinsey
Boehringer Ingelheim

Last Updated: December 11, 2019

DrugPatentWatch Database Preview

PREDNISOLONE SODIUM PHOSPHATE Drug Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Which patents cover Prednisolone Sodium Phosphate, and what generic alternatives are available?

Prednisolone Sodium Phosphate is a drug marketed by Watson Labs, Akorn, Alcon Pharms Ltd, Bausch And Lomb, Sola Barnes Hind, Amneal Pharms, Chartwell Rx, Edenbridge Pharms, Hi Tech Pharma, Medicis Pharms, Mission Pharma, Nesher Pharms, Pharm Assoc, Vintage, Vintage Pharms, We Pharms, Wockhardt Bio Ag, and Mylan Pharms Inc. and is included in twenty-eight NDAs.

The generic ingredient in PREDNISOLONE SODIUM PHOSPHATE is prednisolone sodium phosphate. There are eighty-eight drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the prednisolone sodium phosphate profile page.

US ANDA Litigation and Generic Entry Outlook for Prednisolone Sodium Phosphate

A generic version of PREDNISOLONE SODIUM PHOSPHATE was launched as prednisolone sodium phosphate by BAUSCH AND LOMB on December 11th, 2019.

Drug patent expirations by year for PREDNISOLONE SODIUM PHOSPHATE
Recent Clinical Trials for PREDNISOLONE SODIUM PHOSPHATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Research to Prevent BlindnessPhase 2
Francis I. Proctor FoundationPhase 2
ORA, Inc.Phase 4

See all PREDNISOLONE SODIUM PHOSPHATE clinical trials

Recent Litigation for PREDNISOLONE SODIUM PHOSPHATE

Identify potential future generic entrants

District Court Litigation
Case NameDate
Purdue Pharmaceutical v. Actavis Elizabeth LLC2015-05-13
CIMA Labs Inc. v. Barr Laboratories Inc.2008-08-21
Cephalon Inc. v. Barr Pharmaceuticals Inc.2008-07-22

See all PREDNISOLONE SODIUM PHOSPHATE litigation

Pharmacology for PREDNISOLONE SODIUM PHOSPHATE
Synonyms for PREDNISOLONE SODIUM PHOSPHATE
[2-(11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl] dihydrogen phosphate
[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] dihydrogen phosphate
11beta,17,21-Trihydroxypregna-1,4-diene-3,20-dione 21-(dihydrogen phosphate)
11beta,17,21-Trihydroxypregna-1,4-diene-3,20-dione 21-(disodium phosphate)
125-02-0
125P020
1263143-23-2
302-25-0
752SY38R6C
A805337
AB01563113_01
AC-2371
AC1L1J72
AC1L1LDT
AC1L2HDG
AC1L9B41
ACN-043360
AKOS015962823
AKOS025294226
AKOS025310687
AKOS025394281
AN-14017
ANW-41116
API0003920
AT-2935
BC214767
BCP11881
C21H27O8P.2Na
CCG-213527
CHEBI:8379
CHEMBL1201014
CHEMBL1201231
Codelsol
Cortisate-20 (Veterinary)
CS-2878
CTK8B2822
CTK8I0968
D00981
D3918
disodium [2-(11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl)-2-oxo-ethyl] phosphate
disodium [2-(11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl] phosphate
disodium [2-[(8S,9S,10R,11S,13S,14S,17R)-10,13-dimethyl-11,17-bis(oxidanyl)-3-oxidanylidene-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxidanylidene-ethyl] phosphate
disodium [2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] phosphate
Disodium prednisolone 21-phosphate
disodium;[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] phosphate
DTXSID2047480
DTXSID7047481
EINECS 204-722-9
EINECS 206-120-1
FT-0631728
HMS3264J09
HY-B0645
Hydeltrasol
I06-0770
Inflamase
Inflamase Forte
Inflamase Mild
IV021NXA9J
KB-296232
LS-118502
LS-174283
LS-187308
Metreton
Millipred
MolPort-019-991-120
NCGC00249889-01
NSC-759187
NSC759187
Optimyd
Optival
Pediapred (TN)
Pharmakon1600-01505712
Phortisolone
Predair
Predair Forte
Prednesol
Prednisolone (disodium phosphate)
Prednisolone 21-(dihydrogen phosphate)
Prednisolone 21-(disodium phosphate)
Prednisolone 21-phosphate disodium
Prednisolone 21-Phosphate Disodium Salt
Prednisolone disodium phosphate
Prednisolone phosphate
Prednisolone phosphate sodium
Prednisolone sodium phosphate (JP17/USP)
Prednisolone Sodium Phosphate [USAN:JAN]
Prednisolone sodium phosphate [USP:JAN]
Predsol
Predsolan
Pregna-1,4-diene-3,20-dione, 11-beta,17,21-trihydroxy-, 21-(dihydrogen phosphate), disodium salt
Pregna-1,4-diene-3,20-dione, 11-beta,17,21-trihydroxy-, 21-(dihydrogen phosphate),disodium salt
Pregna-1,4-diene-3,20-dione, 11,17-dihydroxy-21-(phosphonooxy)-, disodium salt, (11.beta.)-
Pregna-1,4-diene-3,20-dione, 11,17-dihydroxy-21-(phosphonooxy)-, disodium salt, (11beta)-
Prozorin
PSLP
Q-201615
SBI-0206886.P001
SCHEMBL136773
SCHEMBL1650407
SCHEMBL23563
sodium 2-((8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl phosphate
Sodium prednisolone phosphate
Solucort
ST24049032
TR-003806
UNII-752SY38R6C
UNII-IV021NXA9J
VA11575
Vasocidin Solution
Veripred 20
ZINC4097473
Paragraph IV (Patent) Challenges for PREDNISOLONE SODIUM PHOSPHATE
Tradename Dosage Ingredient NDA Submissiondate
ORAPRED ODT TABLET, ORALLY DISINTEGRATING;ORAL prednisolone sodium phosphate 021959 2010-07-22
PEDIAPRED SOLUTION;ORAL prednisolone sodium phosphate 019157

US Patents and Regulatory Information for PREDNISOLONE SODIUM PHOSPHATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Pharms Inc PREDNISOLONE SODIUM PHOSPHATE prednisolone sodium phosphate TABLET, ORALLY DISINTEGRATING;ORAL 202179-003 Apr 10, 2013 AB RX No No   Start Trial   Start Trial   Start Trial
Wockhardt Bio Ag PREDNISOLONE SODIUM PHOSPHATE prednisolone sodium phosphate SOLUTION;ORAL 075099-001 Jun 28, 2002 AA RX No No   Start Trial   Start Trial   Start Trial
Wockhardt Bio Ag PREDNISOLONE SODIUM PHOSPHATE prednisolone sodium phosphate SOLUTION;ORAL 076895-001 Oct 4, 2004 AA RX No Yes   Start Trial   Start Trial   Start Trial
Watson Labs PREDNISOLONE SODIUM PHOSPHATE prednisolone sodium phosphate INJECTABLE;INJECTION 080517-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Mission Pharma PREDNISOLONE SODIUM PHOSPHATE prednisolone sodium phosphate SOLUTION;ORAL 091396-001 Sep 13, 2010 RX No Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Mallinckrodt
Medtronic
McKinsey
Dow
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.